Home » Stocks » VIVE

Viveve Medical, Inc. (VIVE)

Stock Price: $2.74 USD 0.13 (4.98%)
Updated Jul 23, 2021 4:00 PM EDT - Market closed
After-hours: $2.77 +0.03 (1.10%) Jul 23, 7:58 PM
Market Cap 29.02M
Revenue (ttm) 5.63M
Net Income (ttm) -25.67M
Shares Out 10.59M
EPS (ttm) -7.32
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 23
Last Price $2.74
Previous Close $2.61
Change ($) 0.13
Change (%) 4.98%
Day's Open 2.61
Day's Range 2.52 - 2.87
Day's Volume 714,801
52-Week Range 2.40 - 14.40

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

New code approved by American Medical Association and supported by key medical societies Long-term pathway for potential reimbursement now established for Company's dual-energy noninvasive treatment for...

2 weeks ago - Accesswire

ENGLEWOOD, CO / ACCESSWIRE / July 6, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief executive office...

2 weeks ago - Accesswire

ENGLEWOOD, CO / ACCESSWIRE / June 10, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that the United States Patent and Tradem...

1 month ago - Accesswire

Meeting scheduled to reconvene June 23, 2021 at 12:00 PM Eastern Time Company encourages stockholders to cast their votes ENGLEWOOD, CO / ACCESSWIRE / June 2, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), ...

1 month ago - Accesswire

Shares of Viveve Medical (NASDAQ:VIVE) increased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 2.44% year over year to ($0.80), which missed...

2 months ago - Benzinga

Pivotal SUI PURSUIT trial enrollment underway and accelerating Total revenue of $1.5M for Q1 including sale of 2,450 consumable treatment tips Strengthened patent portfolio in key Asia Pacific markets E...

2 months ago - Accesswire

ENGLEWOOD, CO / ACCESSWIRE / May 6, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that it will report its first quarter 2021...

2 months ago - Accesswire

ENGLEWOOD, CO / ACCESSWIRE / April 1, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that the Taiwan Intellectual Property Of...

3 months ago - Accesswire

Company continuing to advance its U.S. pivotal PURSUIT trial in stress urinary incontinence Conference call to be hosted by Company at 5:00 PM ET today ENGLEWOOD, CO / ACCESSWIRE / March 18, 2021 / Vive...

4 months ago - Accesswire

ENGLEWOOD, CO / ACCESSWIRE / March 2, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief executive offic...

4 months ago - Accesswire

While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.

Other stocks mentioned: CVE, CNTY, KSHB, NMTR
5 months ago - 24/7 Wall Street

Wall Street recommends buying shares of CHF Solutions Inc (NASDAQ:CHFS) and Viveve Medical Inc (NASDAQ:VIVE), which sounds quite unexpected since these two stocks performed very poorly over the prior 52...

Other stocks mentioned: CHFS
6 months ago - GuruFocus

ENGLEWOOD, CO / ACCESSWIRE / January 14, 2021 / Viveve Medical, Inc. ("Viveve") (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced the pricing of an upsized ...

6 months ago - Accesswire

ENGLEWOOD, CO / ACCESSWIRE /  December 17, 2020 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, announced today that it received notice from The NA...

7 months ago - Accesswire

Viveve Medical's (VIVE) CEO Scott Durbin on Q3 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

Viveve Medical (VIVE) news for Tuesday includes positive results from a recent feasibility study pushing VIVE stock higher. The post Viveve Medical News: Why VIVE Stock Is Rocketing 48% Today appeared f...

10 months ago - InvestorPlace

Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q2 2020 Results - Earnings Call Transcript

11 months ago - Seeking Alpha

Inside the top-ranked stocks that have been exhibiting rising price-to-earnings ratios.

Other stocks mentioned: AVGR, BLRX, PTI, VCNX
1 year ago - Zacks Investment Research

Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q4 2019 - Earnings Call Transcript

1 year ago - Seeking Alpha

Viveve Medical, Inc (VIVE) CEO Scott Durbin on Q3 2019 - Earnings Call Transcript

1 year ago - Seeking Alpha

Shave of Viveve Medical Inc. VIVE, -5.01% sank 11% toward a record low in premarket trading Friday, after the provider of health products and women's health services filed for the sale of new common sto...

1 year ago - Market Watch

Viveve Medical's (VIVE) CEO Scott Durbin on Q2 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Viveve Medical (NASDAQ: VIVE) shares are trading lower after the company said its LIBERATE-International trial in SUI patients did not not achieve its primary endpoint.

2 years ago - Benzinga

Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q1 2019 Results - Earnings Call Transcript

2 years ago - Seeking Alpha

Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q4 2018 Results - Earnings Call Transcript

2 years ago - Seeking Alpha

About VIVE

Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Mi... [Read more...]

Industry
Medical Devices
Founded
2005
Stock Exchange
NASDAQ
Ticker Symbol
VIVE
Full Company Profile

Financial Performance

In 2020, Viveve Medical's revenue was $5.48 million, a decrease of -16.57% compared to the previous year's $6.57 million. Losses were -$21.92 million, -48.47% less than in 2019.

Financial Statements

Analyst Forecasts

According to one analyst, the rating for Viveve Medical stock is "Strong Buy" and the 12-month stock price forecast is 9.63.

Price Target
$9.63
Analyst Consensus: Strong Buy